Louis Moore Bacon's SNY Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 265,056 shares of Sanofi (SNY) worth $12.77 M, representing 0.26% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Louis Moore Bacon has maintained this position in SNY for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 225,779 shares. Largest reduction occurred in Q1 2026, reducing 10,004 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Sanofi (SNY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sanofi (SNY) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -10,004 | Reduce 3.64% | 265,056 | $48.18 |
| Q4 2025 | +225,779 | Add 458.15% | 275,060 | $48.46 |
| Q3 2025 | +49,281 | New Buy | 49,281 | $47.20 |
Louis Moore Bacon's Sanofi Investment FAQs
Louis Moore Bacon first purchased Sanofi (SNY) in Q3 2025, acquiring 49,281 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Sanofi (SNY) for 3 quarters since Q3 2025.
Louis Moore Bacon's largest addition to Sanofi (SNY) was in Q4 2025, adding 275,060 shares worth $13.33 M.
According to the latest 13F filing for Q1 2026, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 265,056 shares of Sanofi (SNY), valued at approximately $12.77 M.
As of the Q1 2026 filing, Sanofi (SNY) represents approximately 0.26% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Sanofi (SNY) was 275,060 shares, as reported at the end of Q4 2025.